Drawing for KLOX

USPTO serial 79326947

KLOX

Reviewed by CopyMark Law Group

Reg. 7070588Status 404
Filing date
Status date
Registration date
Jun 6, 2023
Examiner
CLARKE, NANCY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KLOX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick J. Concannon

Patrick J. Concannon Nutter, McClennen & Fish, LLPSeaport West, 155 Seaport BoulevardBoston, MA 02210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
003Cosmetic preparations for use in fields of dermatology, wound healing, dentistry and oral care; cosmetics for use in wound healing, namely, creams, lotions and gels; cosmetic preparations for use in dentistry, namely, tooth cleaning gels and non-medicated mouthwash, the foregoing for use in the cosmetic care of periodontitis, gingivitis, orthodontics, dental implants, and intended for use in combination with a medical device, namely, a lamp; cosmetic preparations for use in dentistry, namely, tooth paste, tooth cleaning gels, non-medicated mouth washSECTION 70 - CANCELLED—
005Medical preparations for use in wound healing, namely, medicated tissue repair preparations for wounds in the form of creams, lotions, gels, foams, anti-inflammatory sprays, and antibacterial sprays and bandages for skin wounds, wound dressings, burn dressing and medical and surgical wounds in the form of membranes, meshes, fibers, fabrics, dressings, absorbent pads, and antibacterial dressings all of the foregoing for application to ulcers, burns, skin disorders, oncological wounds, post-surgical scars, wound infections, chronic and acute wounds, and trauma wounds; Medical preparations for use in wound healing, namely, medicated tissue repair preparations for wounds in the form of creams, lotions, gels, foams, anti-inflammatory sprays, and antibacterial sprays and bandages for skin wounds, wound dressings, burn dressing and medical and surgical wounds in the form of membranes, meshes, fibers, fabrics, dressings, absorbent pads, and antibacterial dressings, the foregoing used in the medical and therapeutic treatment of acute wounds, chronic wounds, burns, and post-surgical scars or scarring; pharmaceutical preparations for skin care, for use in dentistry, wound healing, dermatology and oral care for use with a medical device, namely, a lamp; pharmaceutical preparations for use in dentistry, wound healing, dermatology and oral care; pharmaceutical preparations for use in wound healing, namely, creams, lotions and gels for treatment of wounds, ulcers, skin disorders, oncologic wounds, burns and post-surgical diseases, infections and wounds; veterinary preparations and dressings, namely, lotions, creams, gels, meshes, fiber patches, or membranes impregnated with medicated skin care preparation, the foregoing used in the treatment of disorders of the skin and soft tissues, namely, otitis externa, furuncles, wounds, oral conditions and pyoderma; veterinary pharmaceutical preparations for the treatment of inflammatory skin disorders; veterinary pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; medicated tissue repair preparations and dressings, namely, lotions, creams, gels, and meshes, fiber patches and membranes impregnated with medicated skin care preparation, that aid in tissue repair and are used in the treatment of acute wounds, chronic wounds, furuncles, oral conditions or scarring; medical preparations used in tissue repair for the treatment of acute wounds, chronic wounds and scaring, namely, lotions, creams, gels, membranes impregnated with medicated skin care preparations; pharmaceutical preparations for use in dermatology, namely, for treatment of dermatitis, actinic keratosis, acne, acne scars, rosacea, eczema, psoriasis, rashes, skin irritations and Bowen's disease, said preparations for use in combination with a medical device, namely, a lamp; bandages for skin wounds; wound dressings; wadding for wound dressings; adhesive wound closures, namely, medical adhesives for binding wounds; hemostatics for medical purposes; hemostatic gel matrix preparations for treating wounds; adhesive bandages for skin wounds; anti-adhesion gels for use with wound drainage devices; medical adhesives for binding wounds; pharmaceutical preparations for wounds; pharmaceutical preparations for use in dentistry, namely, medicated toothpaste in the form of a gel and medicated mouthwash, for use in treatments of periodontitis and gingivitis, in the practice of orthodontics, and to treat infection after dental implants, said pharmaceutical preparations for use in combination with a medical device, namely, a lamp; pharmaceutical preparations for use in dentistry, namely, medicated tooth paste, oral gel formulations, namely, medicated brush-on oral care gels, medicated mouthwash and cleaning, namely, medicated mouth rinse; pharmaceutical skin lotions, creams and gels for dermatological use for the treatment of bacterial, fungal, viral and parasitic skin infections, for the treatment of acne, of skin pigmentation diseases, of inflammatory skin disorders, of dermatitis, and for skin rejuvenation; medical preparations used in tissue repair for the treatment of acute wounds, chronic wounds or scarring, namely, lotions, creams, gels and membranes in the form of bandages for skin wounds, wound dressings, burn dressing and medical and surgical woundsMedical preparations for use in wound healing, namely, medicated tissue repair preparations for wounds in the form of creams, lotions, gels, foams, anti-inflammatory sprays, and antibacterial sprays and bandages for skin wounds and wound dressings, the foregoing in the form of membranes, meshes, fibers, fabrics, dressings, absorbent pads, and antibacterial dressings, all of the foregoing for application to ulcers, burns, oncological wounds, post-surgical scars, wound infections, chronic and acute wounds, and trauma wounds; Medical preparations for use in wound healing, namely, medicated tissue repair preparations for the treatment of wounds in the form of creams, lotions, gels, foams, antiinflammatory sprays, and antibacterial sprays and bandages for skin wounds, and wound dressings in the form of membranes, meshes, fibers, fabrics, dressings, absorbent pads, and antibacterial dressings, the foregoing used in the medical and therapeutic treatment of acute wounds, chronic wounds, burns, and post-surgical scars or scarring; pharmaceutical preparations for use in wound healing, namely, creams, lotions and gels for treatment of wounds, ulcers, skin disorders, oncologic wounds, burns and postsurgical diseases, infections and wounds; veterinary preparations and dressings, namely, lotions, creams, gels, meshes, fiber patches, and membranes impregnated with medicated skin care preparations, the foregoing used in the treatment of disorders of the skin and soft tissues, namely, otitis externa, furuncles, wounds, oral conditions and pyoderma; veterinary pharmaceutical preparations for the treatment of inflammatory skin disorders; veterinary pharmaceutical preparations for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; medicated tissue repair preparations and dressings, namely, lotions, creams, gels, and meshes, fiber patches and membranes impregnated with medicated skin care preparations that aid in tissue repair and are used in the treatment of acute wounds, chronic wounds, furuncles and scarring; medical preparations used in tissue repair for the treatment of acute wounds, chronic wounds and scarring, namely, lotions, creams, gels, membranes impregnated with medicated skin care preparations; pharmaceutical preparations for use in dermatology, namely, for treatment of dermatitis, actinic keratosis, acne, acne scars, rosacea, eczema, psoriasis, rashes, skin irritations and Bowen's disease, said preparations intended for use in combination with a medical device, namely, a lamp; bandages for skin wounds; wound dressings; wadding for wound dressings; adhesive wound closures, namely, medical adhesives for binding wounds; hemostatics for medical purposes; hemostatic gel matrix preparations for treating wounds; adhesive bandages for skin wounds; anti-adhesion gels for use with wound drainage devices; medical adhesives for binding wounds; pharmaceutical preparations for wounds; pharmaceutical preparations for use in dentistry, namely, medicated toothpaste in the form of a gel and medicated mouthwash, for use in treatments of periodontitis and gingivitis, in the practice of orthodontics, and to treat infection after dental implants, said pharmaceutical preparations intended for use in combination with a medical device, namely, a lamp; pharmaceutical preparations for use in dentistry, namely, medicated tooth paste, oral gel formulations, namely, medicated brush-on oral care gels, medicated mouthwash; pharmaceutical skin lotions, creams and gels for dermatological use for the treatment of bacterial, fungal, viral and parasitic skin infections, for the treatment of acne, of skin pigmentation diseases, of inflammatory skin disorders, of dermatitis, and for skin rejuvenation; medical preparations used in tissue repair for the treatment of acute wounds, chronic wounds and scarring, namely, lotions, creams, gels and membranes in the form of bandages for skin wounds, wound dressingsSECTION 70 - CANCELLED—
010Medical devices, namely, UV lamps for medical applications, lamps and LED devices for treatment of a variety of skin conditions and light-producing phototherapy lamps, namely, electronic light therapy apparatus for the skin in the nature of a phototherapy apparatus, said medical lamps for use in combination with pharmaceutical creams, lotions and gels, bandages for skin wounds, wound dressings and medical and surgical dressings in the form of membranes, meshes, fibers, foams, absorbent pads, anti-inflammatory sprays and antibacterial sprays, the foregoing for medical treatment of dermatological conditions; Medical devices, namely, lamps in the nature of UV lamps for medical applications, black-light blue lamps units for use in identification of a variety of skins conditions and lamps and LED devices for use in the fields of wound healing, surgery, and dermatology; lamps and lights, namely, UV lamps for medical applications, lamps and LED devices for treatment of a variety of skin conditions, light-producing phototherapy lamps, namely, electronic light therapy apparatus for the skin, namely, a phototherapy apparatus for use in medical and cosmetic dermatological procedures; phototherapeutic apparatus for medical purposes, namely, a LED (light-emitting diode) light source for medical and aesthetic skin treatments; medical devices for use in dermatology, dentistry and wound healing, namely, UV lamps for medical applications, curing lamps for medical purposes and light-producing phototherapy lamps, namely, electronic light therapy apparatus for the skin for the purpose of phototherapySECTION 70 - CANCELLED—
011Lamps and lights in the nature of magnifying lamps used in cosmetic salons, not for medical purposes; lamps and lights for use in the illumination of chromophore devices, namely, various skin malformations, skin infections, skin pigmentation diseases, inflammatory skin disorders and skin wounds, not for medical purposesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 7, 2024DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 3, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 11, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 11, 2023FIMPFINAL DISPOSITION PROCESSED—
Sep 6, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 6, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 6, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 22, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 3, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 3, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 21, 2023GPNXNOTIFICATION PROCESSED BY IB—
Mar 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 1, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 1, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 16, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 16, 2023DMCCDATA MODIFICATION COMPLETED—
Feb 16, 2023ALIEASSIGNED TO LIE—
Feb 15, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Feb 15, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 15, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 15, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 1, 2022GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 1, 2022GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 1, 2022CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 10, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 23, 2022RFNTREFUSAL PROCESSED BY IB—
Jan 4, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 4, 2022RFRRREFUSAL PROCESSED BY MPU—
Dec 11, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 10, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 7, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 3, 2021DOCKASSIGNED TO EXAMINER—
Dec 3, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 2, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance